About Index Trending news
Analyze
Pricing
Fractyl Labs

Fractyl Labs

Work at Fractyl Labs? Add yourself to this profile

Fractyl Labs

Developing an Innovative Endoscopic Outpatient Procedure to Improve Glycemic Control for Type 2 Diabetes
Edit Profile
More info

Elsewhere

Contributors to this profile

Companies in the same industry

Biolase Biolase EasySense EasySense CALCIVIS LIMITED CALCIVIS LIMITED XACT Robotics XACT Robotics Gauss Surgical Gauss Surgical CliniCloud CliniCloud Fimmic Fimmic Titan Medical Inc Titan Medical Inc Stryker Corp Stryker Corp angelMD angelMD

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 4
Add info
Latest funding Show all
Venture capital
$47,170,000
Venture capital (Series C)
$57,000,000
Bessemer Venture Partners, General Catalyst Partners, Domain Associates, +2
Employees

Team size

10+
Locations
HQ
United States
Headquarters
$57,000,000 Venture capital (Series C)
BioPortfolio

Fractyl Announces Completion of $57 Million Series C Investment

Fractyl Labs
Fractyl Labs
$19,760,000 Venture capital (Series B)
TechCrunch

Fractyl Labs Raises $40M Series C To Develop Diabetes Treatments

Fractyl Labs
Fractyl Labs